Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia.
Journal: Bone marrow transplantation
Published: April 21, 2025
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 17, 2024
Dasatinib-associated follicular lymphoma in a patient with B-cell acute lymphoblastic leukaemia.
Journal: BMJ case reports
Published: May 17, 2023
Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma.
Journal: Cancer investigation
Published: January 19, 2023
Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects.
Journal: American journal of hematology
Published: December 16, 2019
Allogenic hematopoietic stem cell transplantation in sickle cell disease.
Journal: Current opinion in hematology
Published: September 07, 2019
Can Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predict Chimeric Antigen Receptor T Cell Adverse Effects?
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: April 08, 2019
Finding the right BCR-ABL1 tyrosine kinase inhibitor: a case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilotinib.
Journal: BMC cancer
Published: March 23, 2018
Last Updated: 09/26/2026